Federal Register / Vol. 73, No. 42 / Monday, March 3, 2008 / Notices 11425 

Contact Person: Kan Ma, PhD, Scientific 

Review Administrator, NIH/NIAMS, EP 

Review Branch, One Democracy Plaza, Suite 

800, Bethesda, MD 20892–4872, 301–594–

4952, mak2@mail.NIH.gov. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel, Small 

Research Grants Review. 

Date: March 25, 2008. 

Time: 8:30 a.m. to 4:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892. 

Contact Person: Eric H. Brown, PhD, 

Scientific Review Officer, National Institute 

of Arthritis and Musculoskeletal Skin 

Diseases, National Institutes of Health, 6701 

Democracy Blvd, Room 824, MSC 4872, 

Bethesda, MD 20892–4874, (301) 594–4955, 

browneri@mail.nih.gov. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel, Vascular 

Diseases Clinical Trial. 

Date: April 3, 2008. 

Time: 1 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Charles H. Washabaugh, 

PhD, Scientific Review Administrator, 

Review Branch, NIAMS/NIH, 6701 

Democracy Blvd, Room 816, Bethesda, MD 

20892, 301 451–4838, 

washabac@mail.nih.gov. 

Name of Committee: National Institute of 

Arthritis and Musculoskeletal and Skin 

Diseases Special Emphasis Panel, 

Musculoskeletal Diseases Clinical Trial 

Planning Grant. 

Date: April 4, 2008. 

Time: 1 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, One 

Democracy Plaza, 6701 Democracy 

Boulevard, Bethesda, MD 20892 (Telephone 

Conference call). 

Contact Person: Eric H. Brown, PhD, 

Scientific Review Officer, National Institute 

of Arthritis and Musculoskeletal Skin 

Diseases, National Institutes of Health, 6701 

Democracy Blvd, Room 824, MSC 4872, 

Bethesda, MD 20892–4874, (301) 594–4955, 

browneri@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.846, Arthritis, 

Musculoskeletal and Skin Diseases Research, 

National Institutes of Health, HHS) 

Dated: February 25, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–905 Filed 2–29–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute On Aging; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute on 

Aging Special Emphasis Panel, March 

10, 2008, 7 a.m. to March 11, 2008, 5 

p.m., Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 

20817 which was published in the 

Federal Register on February 4, 2008, 

73 FR 6519. 

Meeting will begin at 6 p.m. on March 

10, 2008. The meeting is closed to the 

public. 

Dated: February 21, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–907 Filed 2–29–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Mental Health; 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Mental Health Special Emphasis Panel; 

Services in Non-Specialty Setting. 

Date: March 11, 2008. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Neuroscience Center, 6001 Executive 

Boulevard, Rockville, MD 20852, (Telephone 

Conference Call). 

Contact Person: Aileen Schulte, PhD, 

Scientific Review Administrator, Division of 

Extramural Activities, National Institute of 

Mental Health, NIH, Neuroscience Center, 

6001 Executive Blvd., Room 6140, MSC 9608, 

Bethesda, MD 20892–9608, 301–443–1225, 

aschulte@mail.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.242, Mental Health Research 

Grants; 93.281, Scientist Development 

Award, Scientist Development Award for 

Clinicians, and Research Scientist Award; 

93.282, Mental Health National Research 

Service Awards for Research Training, 

National Institutes of Health, HHS) 

Dated: February 25, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–909 Filed 2–29–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Hematology 

Small Business. 

Date: March 13–14, 2008. 

Time: 11 a.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Delia Tang, MD, Scientific 

Review Officer, Center for Scientific Review, 

National Institutes of Health, 6701 Rockledge 

Drive, Room 4126, MSC 7802, Bethesda, MD 

20892, 301–435–2506, tangd@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Small 

Business: Drug Discovery. 

Date: March 18, 2008. 

Time: 1:30 p.m. to 3 p.m. 


rmajette on PROD1PC64 with NOTICES
11426 Federal Register / Vol. 73, No. 42 / Monday, March 3, 2008 / Notices 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Marian Wachtel, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3208, 

MSC 7858, Bethesda, MD 20892, 301–435–

1148, wachtelm@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Immunology 

Member Conflicts: Leukocytes, Lymphocytes, 

and Inflammation. 

Date: March 18, 2008. 

Time: 1:30 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Stephen M. Niqida, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4212, 

MSC 7812, Bethesda, MD 20892, 301–435–

1222, niqidas.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Endocrinology, Metabolism and 

Reproductive Sciences. 

Date: March 20, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Legacy Hotel and Meeting 

Centre, 1775 Rockville Pike, Rockville, MD 

20852. 

Contact Person: Krish Krishnan, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 6164, 

MSC 7892, Bethesda, MD 20892, (301) 435–

1041, krishnak@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Special 

Emphasis Panel for Member Conflict. 

Date: March 24, 2008. 

Time: 11:30 a.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Jose H. Guerrier, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5218, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1137, guerriej@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, NAED 

Reviewer Conflicts. 

Date: March 26–27, 2008. 

Time: 8 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Eduardo A. Montalvo, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5212, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1168, montalve@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Lymphangiogenesis. 

Date: March 31, 2008. 

Time: 1:30 p.m. to 3 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Telephone Conference Call). 

Contact Person: Larry Pinkus, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4132, 

MSC 7802, Bethesda, MD 20892, (301) 435–

1214, pinkus@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, AMCB, 

ADDT, ACE and AIP Reviewer Conflicts. 

Date: April 2–3, 2008. 

Time: 8 a.m. to 6:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Eduardo A. Montalvo, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5212, 

MSC 7852, Bethesda, MD 20892, (301) 435–

1168, montalve@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, PAR 301–

368: MLPCN U02 Review Meeting. 

Date: April 3–4, 2008. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Doubletree Hotel Washington, DC, 

1515 Rhode Island Avenue, NW., 

Washington, DC 20005. 

Contact Person: Joseph G. Rudolph, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5186, 

MSC 7844, Bethesda, MD 20892, (301) 435–

2212, josephru@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.392–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

February 25, 2008. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 08–904 Filed 2–29–08; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HOMELAND 

SECURITY 

Federal Emergency Management 

Agency 

[FEMA–1745–DR] 

Tennessee; Major Disaster and Related 

Determinations 

AGENCY: Federal Emergency 

Management Agency, DHS. 

ACTION: Notice. 

SUMMARY: This is a notice of the 

Presidential declaration of a major 

disaster for the State of Tennessee 

(FEMA–1745–DR), dated February 7, 

2008, and related determinations. 

EFFECTIVE DATE: February 7, 2008. 

FOR FURTHER INFORMATION CONTACT: 

Peggy Miller, Disaster Assistance 

Directorate, Federal Emergency 

Management Agency, 500 C Street, SW., 

Washington, DC 20472, (202) 646–2705. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given that, in a letter dated 

February 7, 2008, the President declared 

a major disaster under the authority of 

the Robert T. Stafford Disaster Relief 

and Emergency Assistance Act, 42 

U.S.C. 5121–5206 (the Stafford Act), as 

follows: 

I have determined that the damage in 

certain areas of the State of Tennessee 

resulting from severe storms, tornadoes, 

straight-line winds, and flooding during the 

period of February 5–6, 2008, is of sufficient 

severity and magnitude to warrant a major 

disaster declaration under the Robert T. 

Stafford Disaster Relief and Emergency 

Assistance Act, 42 U.S.C. 5121–5206 (the 

Stafford Act). Therefore, I declare that such 

a major disaster exists in the State of 

Tennessee. 

In order to provide Federal assistance, you 

are hereby authorized to allocate from funds 

available for these purposes such amounts as 

you find necessary for Federal disaster 

assistance and administrative expenses. 

You are authorized to provide Individual 

Assistance and assistance for debris removal 

and emergency protective measures 

(Categories A and B) under the Public 

Assistance program in the designated areas, 

Hazard Mitigation throughout the State, and 

any other forms of assistance under the 

Stafford Act that you deem appropriate 

subject to completion of Preliminary Damage 

Assessments (PDAs), unless you determine 

that the incident is of such unusual severity 

and magnitude that PDAs are not required to 

determine the need for supplemental Federal 

assistance pursuant to 44 CFR 206.33(d). 

Consistent with the requirement that 

Federal assistance be supplemental, any 

Federal funds provided under the Stafford 

Act for Hazard Mitigation and Other Needs 

Assistance will be limited to 75 percent of 

the total eligible costs. Federal funds 

provided under the Stafford Act for Public 

Assistance also will be limited to 75 percent 


rmajette on PROD1PC64 with NOTICES